Operon Biotech

Executive Summary

Operon Biotech is an Indian diagnostics and med-tech company specializing in coagulation analyzers, point-of-care (POCT) devices, and related reagents. Founded in 2020 and based in Mumbai, the company leverages in-house engineering and partnerships with global IVD firms to deliver affordable, high-quality hematology and biochemistry solutions. Its products target hospitals, clinical laboratories, and government health programs, addressing the growing demand for cost-effective diagnostic tools in emerging markets. The company operates in the commercial stage with 50–200 employees and competes by offering reliable, low-cost alternatives to established diagnostics brands. While financial details remain undisclosed, Operon Biotech is well-positioned to benefit from India's focus on expanding healthcare infrastructure and public health screening. Key growth drivers include potential contract wins under government health initiatives, deepening partnerships with multinational IVD companies, and the launch of next-generation POCT analyzers. Continued expansion in tier-2/3 cities and rural areas could significantly accelerate revenue.

Upcoming Catalysts (preview)

• TBDNew Point-of-Care Coagulation Analyzer Launch70% success
• H2 2026Distribution Partnership with Global IVD Firm60% success
• 2026Government Tender Award for Rural Health Programs55% success